Impact of Intratumoral Inflammation on Survival after Pancreatic Cancer Resection

Pancreas

Volumn 45, Issue 1, 2016, Pages 123-126

  Hart, Phil A ^a   Smyrk, Thomas C ^a   Bamlet, William R ^a   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

Author keywords

inflammation; macrophage; mast cell; pancreatic cancer; survival

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPH NODE METASTASIS; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; FACTUAL DATABASE; IMMUNOLOGY; MIDDLE AGED; MORTALITY; NEUTROPHIL; ODDS RATIO; PANCREATIC NEOPLASMS; PANCREATITIS; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; NEOPLASM GRADING; NEUTROPHILS; ODDS RATIO; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATITIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84952716628     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000423     Document Type: Article

References (21)

1. Siegel R, Ma J, Zou Z, CA Cancer J Clin. 2014; 64: 9-29.
2. Barugola G, Partelli S, Marcucci S, Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol. 2009; 16: 3316-3322.
3. Greer JB, Whitcomb DC,. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol. 2009; 9: 411-418.
4. Ene-Obong A, Clear AJ, Watt J, Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology. 2013; 145: 1121-1132.
5. Ino Y, Yamazaki-Itoh R, Shimada K, Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 2013; 108: 914-923.
6. Protti MP, De Monte L,. Immune infiltrates as predictive markers of survival in pancreatic cancer patients. Front Physiol. 2013; 4: 210.
7. Theoharides TC, Kempuraj D, Tagen M, Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007; 217: 65-78.
8. Cai SW, Yang SZ, Gao J,. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery. 2011; 149: 576-584.
9. Chang DZ, Ma Y, Ji B, Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011; 17: 7015-7023.
10. Strouch MJ, Cheon EC, Salabat MR, Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res. 2010; 16: 2257-2265.
11. Apte MV, Wilson JS,. Stellate cell activation in alcoholic pancreatitis. Pancreas. 2003; 27: 316-320.
12. Kurahara H, Shinchi H, Mataki Y, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011; 167: e211-e219.
13. Yoshikawa K, Mitsunaga S, Kinoshita T, Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci. 2012; 103: 2012-2020.
14. Bachem MG, Schunemann M, Ramadani M, Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005; 128: 907-921.
15. Hwang RF, Moore T, Arumugam T, Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008; 68: 918-926.
16. Vonlaufen A, Joshi S, Qu C, Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008; 68: 2085-2093.
17. Erkan M, Michalski CW, Rieder S, The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2008; 6: 1155-1161.
18. Rochefort MM, Ankeny JS, Kadera BE, Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Ann Surg Oncol. 2013; 20: 4322-4329.
19. Wasif N, Ko CY, Farrell J, Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010; 17: 2312-2320.
20. Lim JE, Chien MW, Earle CC,. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003; 237: 74-85.
21. Winter JM, Cameron JL, Campbell KA, 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006; 10: 1199-1210.